467 Results (Page 1 of 19)
Brazil Markets Research Reports
Brazil Connected Healthcare Market Analysis
Brazil's connected healthcare market is projected to grow from $1.66 Bn in 2022 to $13.04 Bn by 2030, registering a CAGR of 29.4% during the forecast period of 2022-30. The main factors driving the growth would be the growing demand for healthcare services, technological innovations, government initiatives, and the aging population. The market is segmented by type, function, and application. Some of the major players include Dr.Consulta, Grupo Fleury, Pixeon, Siemens Healthineers, GE Healthcare, and Medtronic.
Brazil Antiviral Drugs Market Analysis
This report presents a strategic analysis of the Brazil Antiviral Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Antiviral Drugs Market, offering unmatched value, accuracy and expert insights.
Brazil Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the Brazil Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Vitamin and Minerals Market, offering unmatched value, accuracy and expert insights.
Brazil Primary Hyperoxaluria (PH) Therapeutics Market Analysis
Brazil Primary Hyperoxaluria (PH) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. One of the key factors propelling the growth of the hyperoxaluria drug market is the rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Therapeutics Market are Allena Pharmaceuticals, Inc., Intellia Therapeutics, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
Brazil Dental Caries Detectors Market Analysis
The Brazil Dental Caries Detectors Market was valued at $5.7 Mn in 2023 and is predicted to grow at a CAGR of 9.9% from 2023 to 2030, to $11 Mn by 2030. Brazil Dental Caries Detectors Market is growing due to the High prevalence of dental caries, Growing awareness, and Advanced imaging and diagnostics. The market is primarily dominated by players such as Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, Planmeca Oy, Adec Technologies, 3M ESPE, Morita Corporation, Woodpecker Medical Instruments Co., Softdent.
Brazil Clinical Nutrition for Diabetes Care Market Analysis
The Brazil Clinical Nutrition for Diabetes Care Market was valued at $53.75 Mn in 2023 and is predicted to grow at a CAGR of 5.78% from 2023 to 2030, to $79.65 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Nutribio, Pfizer Inc., and Novo Nordisk among others.
Brazil Pharmacy Automation Device Market Analysis
The Brazil Pharmacy Automation Device Market was valued at $137.5 Mn in 2023 and is predicted to grow at a CAGR of 10.9% from 2023 to 2030, to $283.7 Mn by 2030. Brazil Pharmacy Automation Device Market is growing due to Increasing Healthcare Expenditure, Adoption of Electronic Health Records, Technological Advancements. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter.
Brazil Cardiac Pacemakers Market Analysis
The Brazil Cardiac Pacemakers Market was valued at $101.17 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $134.94 Mn by 2030. The key drivers of this industry include the high prevalence of cardiovascular diseases, the aging population, and healthcare infrastructure. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Brazil Biosensors Market Analysis
The Brazil Biosensors Market was valued at $722.5 Mn in 2023 and is predicted to grow at a CAGR of 9% from 2023 to 2030, to $1320.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing demand for Point-of-Care (POC) testing. The prominent players of the Brazil Biosensors Market are Biosensor Indústria e Comércio, BioCen Do Brazil, Abbott Laboratories, Medtronic, and Siemens Healthcare, among others.
Brazil Ankylosing Spondylitis Therapeutics Market Analysis
Brazil Ankylosing Spondylitis Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Ankylosing spondylitis is a kind of arthritis that affects connective tissues. The sacroiliac joints, which connect the spine to the pelvis, become inflamed, but in extreme situations, the spine's bones might fuse together and become very inflexible. A rough estimate of 1.1 Mn Americans, or one out of every 200 adults, are impacted. Abbvie, Amgen, Eli Lilly, Janssen, Merck, Pfizer, Novartis, UCB, and many other leading companies are active in the ankylosing spondylitis global market. To increase their market share, these businesses engage in strategic alliances and acquisitions in addition to concentrating on research and development to bring novel therapies to market.
Brazil Insulin Market Analysis
This report presents a strategic analysis of the Brazil Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Insulin Market, offering unmatched value, accuracy and expert insights.
Brazil Clinical Nutrition for Cancer Care Market Analysis
The Brazil Clinical Nutrition for Cancer Care Market was valued at $140.8 Mn in 2023 and is predicted to grow at a CAGR of 6.04% from 2023 to 2030, to $212.2 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, improved healthcare infrastructure, and rising disposable incomes. The prominent players of the Brazil Clinical Nutrition for Cancer Care Market are Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, and Fresenius Kabi, among others.
Brazil Gram-Negative Infection Therapeutics Market Analysis
The Brazil Gram-Negative Infection Therapeutics Market was valued at $371.9 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030 to $593.29 Mn by 2030. Key market growth drivers include the increasing prevalence of gram-negative infections, rising antibiotic resistance, and technological advancements. Major players in this market include Nektar Therapeutics, Novartis, and other notable companies.
Brazil Home Infusion Therapy Market
The Brazil Home Infusion Therapy Market was valued at $899 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $1654 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Brazil Home Infusion Therapy Market are Poly Medicure, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Brazil Hepatitis A Therapeutics Market Analysis
The Brazil Hepatitis A Therapeutics Market was valued at $18.43 Mn in 2023 and is predicted to grow at a CAGR of 3.2% from 2023 to 2030 to $22.98 Mn by 2030. Key drivers of this market include increasing prevalence, successful vaccination programs, and various public health initiatives. Prominent companies in this sector include Eurofarma and EMS Pharmaceuticals, among others.
Brazil Fibrodysplasia Ossificans Progressiva Drugs Market Analysis
Brazil Fibrodysplasia Ossificans Progressiva Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for Fibrodysplasia Ossificans Progressiva Drugs is expanding as a result of growing incidence and prevalence of fibrodysplasia ossificans progressiva , increase in the number of R&D activities, increase in Partnerships and Collaborations between market players. Pfizer Inc., AstraZeneca, Limited, Regeneron Pharmaceuticals, Inc, Clementia Pharmaceuticals, Novartis are the top key market players operating in the global Fibrodysplasia Ossificans Progressiva Drugs market.
Brazil Guillain-Barre Syndrome (GBS) Drugs Market Analysis
Brazil Guillain-Barre Syndrome (GBS) drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Guillain-Barre Syndrome (GBS) drugs is growing rapidly as a result of increase in the incidence and prevalence of the guillain-barre syndrome, advancements in technology and development in healthcare, support and funding by governments globally, rise in the geriatric population and increase in the prevalence of chikungunya and immune diseases like multiple sclerosis , increase in the approvals of immunoglobulins by regulatory bodies and increase in research and development activities by pharmaceutical companies. Alexion Pharmaceuticals Inc., Annexon Inc., Cellenkos Inc., Cresence AS, Akari Therapeutics Plc, Chugai Pharmaceutical Co Ltd are the key market players operating in global gullian barre syndrome drugs market.
Brazil Primary Hyperoxaluria (PH) Drugs Market Analysis
Brazil Primary Hyperoxaluria (PH) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Unmet Medical Need, Increasing Awareness and Diagnosis, Advancements in Research and Development, Growing Investment and Pipeline Development, Collaboration and Patient Advocacy,rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Drugs Market are Allena Pharmaceuticals, Inc., Intellia Drugs, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
Brazil Neurology Drugs Market Analysis
This report presents a strategic analysis of the Brazil Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Neurology Drugs Market, offering unmatched value, accuracy and expert insights.
Brazil Palliative Care Market Analysis
The Brazil Palliative care market is projected to grow from $327 Mn in 2022 to $651.57 Mn by 2030, registering a CAGR of 9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the aging population, increasing prevalence of chronic diseases, and government support. The market is segmented by service type and by the end user. Some of the major players include Hospital Estadual Americo Brasiliense, Hospital Sirio Libanes, Cariri Regional Hospital, GRAACC Hospital, and Hospital Group Conceicao.
Brazil Batten's Disease (CLN-2) Therapeutics Market Analysis
Brazil Batten?s Disease (CLN-2) Therapeutics market is projected to grow from $6 Mn in 2022 to $11.53 Mn by 2030, registering a CAGR of 8.5% during the forecast period of 2022-2030. Neuronal Ceroid Lipofuscinosis (NCL), often known as Batten disease, is a rare and severe autosomal recessive neurodegenerative lysosomal storage condition brought on by cellular buildup of aberrant auto-fluorescent lipoproteins (lipofuscin). Seizures and a progressive loss of movement, verbal, visual, and cognitive abilities are features of this neurodegenerative condition that primarily affects the nerve system. Research advancements in nanotechnology could result in the creation of fresh therapies that would benefit persons who suffer from this ailment. Additionally, it is a paediatric brain condition that is extremely rare yet progresses quickly. As a result, Batten's Disease may be exacerbated by the predicted rising prevalence of disease. Therapeutics market (CLN-2). The market for Batten's Disease (CLN-2) Therapeutics is constrained by a lack of treatment and symptoms that are challenging to identify. Regenxbio, Polaryx Therapeutics, and Abeona Therapeutics are some of the key players in the market.
Brazil Lymphoma Therapeutics Market Analysis
Brazil's Lymphoma Therapeutics Market was valued at $431.38 Mn in 2023 and is predicted to grow at a CAGR of 8.80 % from 2023 to 2030, to $778.51 Mn by 2030. The key drivers of this industry include an increasing incidence of lymphomas, robust pipeline products, growing geriatric population. The industry is primarily dominated by Bristol-Myers Squibb Company, Merck & Co., Novartis AG, Johnson & Johnson, GSK plc, and AstraZeneca plc among others.
Brazil Head and Neck Cancer Therapeutics Market Analysis
The Brazil Head and Neck Cancer Therapeutics Market was valued at $75.83 Mn in 2023 and is predicted to grow at a CAGR of 13.00% from 2023 to 2030, to $178.41 Mn by 2030. The key drivers of this industry include rising incidence, advancement in research, and government initiatives. The industry is primarily dominated by players such as Pfizer, Merck, Novartis, and AstraZeneca among others.
Brazil Adrenoleukodystrophy (ALD) Therapeutics Market Analysis
Brazil Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the Brazil Adrenoleukodystrophy (ALD) drugs market.
Brazil COVID-19 Clinical Trials Market Analysis
This report presents a strategic analysis of the Brazil COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil COVID-19 Clinical Trials Market, offering unmatched value, accuracy and expert insights.